Longboard Pharmaceuticals News

Longboard Pharmaceuticals | 8-K: Longboard Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Updates

Nov 7 16:08 ET

Longboard Pharmaceuticals | 8-K: Current report

Oct 15 06:23 ET

Longboard Pharmaceuticals | 8-K: Longboard Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Corporate Updates

Aug 1 16:12 ET

Longboard Pharmaceuticals | 8-K: Current report

Jul 1 09:19 ET

Longboard Pharmaceuticals | 8-K: Current report

Jun 10 09:08 ET

Longboard Pharmaceuticals | 8-K: Current report

May 24 16:09 ET

Longboard Pharmaceuticals | 8-K: Longboard Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Updates

May 2 16:16 ET

Longboard Pharmaceuticals | 8-K: Current report

Apr 15 09:18 ET

Longboard Pharmaceuticals | DEFA14A: Others

Apr 12 16:21 ET

Longboard Pharmaceuticals | DEF 14A: Definitive information statements

Apr 12 16:08 ET

Longboard Pharmaceuticals | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Mar 28 16:45 ET

Longboard Pharmaceuticals | 8-K: Current report

Mar 26 17:30 ET

Longboard Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 12 17:11 ET

Longboard Pharmaceuticals | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

Mar 12 16:50 ET

Longboard Pharmaceuticals | 8-K: Current report

Mar 12 16:15 ET

Longboard Pharmaceuticals | 8-K: Current report

Jan 4 00:00 ET

Longboard Pharmaceuticals | 8-K: Current report

Jan 2 00:00 ET

Longboard Pharmaceuticals | 8-K: Current report

Jan 2 00:00 ET

Longboard Pharmaceuticals | 8-K: Current report

Nov 29, 2023 08:35 ET

Longboard Pharmaceuticals | 8-K: Longboard Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2023 Financial Results

Nov 2, 2023 16:05 ET